Your session is about to expire
← Back to Search
Corticosteroid
NSAID for Glaucoma
N/A
Waitlist Available
Led By Graham Trope, MD FRCSC
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
All Individual Drugs Already Approved
No Placebo-Only Group
Approved for 60 Other Conditions
Summary
This study aims to evaluate the eye pressure response to non-steroidal anti-inflammatory eye drops as compared to steroid eye drops following glaucoma surgery.
Eligible Conditions
- Glaucoma
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Approved for 60 Other Conditions
This treatment demonstrated efficacy for 60 other conditions.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: NSAIDExperimental Treatment1 Intervention
Group II: SteroidsActive Control1 Intervention
Find a Location
Who is running the clinical trial?
University Health Network, TorontoLead Sponsor
1,520 Previous Clinical Trials
503,208 Total Patients Enrolled
7 Trials studying Glaucoma
226 Patients Enrolled for Glaucoma
Graham Trope, MD FRCSCPrincipal InvestigatorUniversity Health Network, Toronto
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger